Related Experiment Video
Updated: Apr 24, 2026
10:28
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
7.7K
Advances in percutaneous coronary interventions for elderly patients
Jorge A Brenes-Salazar1, Daniel E Forman
1Saint Mary's Hospital, Mayo Clinic, Rochester, MN 55901, USA.
Progress in Cardiovascular Diseases
|September 14, 2014
Summary
Percutaneous coronary interventions (PCI) benefit older adults with coronary heart disease (CHD), despite higher complication risks. Evidence supports PCI in elderly patients, guiding treatment decisions for this growing population.
Area of Science:
- Cardiology
- Geriatric Medicine
- Interventional Cardiology
Background:
- Coronary heart disease (CHD) is a major cause of death in older adults.
- Elderly patients are often excluded from cardiovascular trials, complicating treatment decisions.
- Managing CHD in the elderly is challenging due to comorbidities and aging.
Purpose of the Study:
- To review current evidence on percutaneous coronary interventions (PCI) in older adults with stable and unstable CHD.
- To compare different PCI strategies and stent types in the elderly population.
- To discuss adjuvant therapies for elderly patients undergoing PCI.
Main Methods:
- Review of existing clinical trials and registry data on PCI in older adults.
- Comparison of outcomes based on stent type (drug-eluting vs. bare-metal).
- Analysis of procedural access routes (transfemoral vs. transradial) and revascularization methods.
Main Results:
- Elderly patients may derive significant benefit from PCI, sometimes exceeding that of younger patients.
- Older adults experience a higher rate of overall complications following PCI.
- Evidence supports the use of PCI in elderly patients with CHD, with careful consideration of risks and benefits.
Conclusions:
- PCI is increasingly utilized in older adults with CHD, demonstrating potential benefits.
- Careful patient selection and management are crucial to mitigate higher complication rates in the elderly.
- Further research is needed to optimize PCI strategies for the aging population with CHD.
Keywords:
Cardiovascular diseaseCoronary artery diseaseElderly patientPercutaneous coronary interventionMore Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
4.0K
08:12Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels
Published on: May 26, 2023
2.9K
Related Concept Videos
01:27Peripheral Artery Disease III: Interprofessional Care
649
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
649
01:28Acute Coronary Syndrome IV: Interprofessional Care
514
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
514
01:27Coronary Artery Disease V: Interprofessional Care
442
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
442
01:15Drug Dosing: Geriatric Patients
392
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
392
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
354
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
354
01:26Angina IV: Management
483
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
483